Newman James W. Jr. 4
4 · ADIAL PHARMACEUTICALS, INC. · Filed May 25, 2023
Insider Transaction Report
Form 4
Newman James W. Jr.
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-05-23+50,000→ 50,000 totalExercise: $0.30From: 2023-05-23Exp: 2033-05-23→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]The option vests pro rata on a monthly basis over 36 months commencing May 23, 2023.